Page last updated: 2024-10-31

methylphenidate and Cold Fingers, Hereditary

methylphenidate has been researched along with Cold Fingers, Hereditary in 6 studies

Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Umair, HM1
Sandler, RD1
Alunno, A1
Matucci-Cerinic, M1
Hughes, M1
Iglesias Otero, M1
Portela Romero, M1
Bugarín González, R1
Ventura Victoria, MA1
Bayram, Ö1
Hergüner, S1
Goldman, W1
Seltzer, R1
Reuman, P1
Syed, RH1
Moore, TL1
Kochar, MS1

Reviews

1 review available for methylphenidate and Cold Fingers, Hereditary

ArticleYear
Association between central nervous system stimulants used to treat attention deficit hyperactivity disorder (ADHD) and Raynaud's phenomenon: A scoping review.
    Seminars in arthritis and rheumatism, 2021, Volume: 51, Issue:6

    Topics: Adolescent; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central

2021

Other Studies

5 other studies available for methylphenidate and Cold Fingers, Hereditary

ArticleYear
[Methylphenidate and secondary Raynaud's phenomenon].
    Semergen, 2013, Volume: 39, Issue:6

    Topics: Adolescent; Central Nervous System Stimulants; Humans; Male; Methylphenidate; Raynaud Disease

2013
OROS-Methylphenidate-Induced Raynaud's Phenomenon: A Dose-Related Side Effect.
    Journal of child and adolescent psychopharmacology, 2015, Volume: 25, Issue:6

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dose-R

2015
Association between treatment with central nervous system stimulants and Raynaud's syndrome in children: a retrospective case-control study of rheumatology patients.
    Arthritis and rheumatism, 2008, Volume: 58, Issue:2

    Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Case-Control Studies; Central Nerv

2008
Methylphenidate and dextroamphetamine-induced peripheral vasculopathy.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2008, Volume: 14, Issue:1

    Topics: Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dext

2008
Simultaneous treatment of Raynaud's phenomenon and orthostatic hypotension.
    The American journal of medicine, 1983, Volume: 75, Issue:3

    Topics: Drug Therapy, Combination; Ephedrine; Female; Fludrocortisone; Follow-Up Studies; Humans; Hydralazin

1983